Focused on the discovery and development of novel therapeutics acting exclusively in the gastrointestinal tract and devoid of systemic exposure

Sectors
Healthcare
Life Sciences
First Invested
2008
Early
Company Status
IPO/Public
NASDAQ: ARDX